How, with whom and when: an overview of CD147-mediated regulatory networks influencing matrix metalloproteinase activity
Open accessThe DOI matches its Crossref record; 153 of the 153 references it cites were found in a registry or an index.
Abstract
Matrix metalloproteinases (MMPs) comprise a family of 23 zinc-dependent enzymes involved in various pathologic and physiologic processes. In cancer, MMPs contribute to processes from tumour initiation to establishment of distant metastases. Complex signalling and protein transport networks regulate MMP synthesis, cell surface presentation and release. Earlier attempts to disrupt MMP activity in patients have proven to be intolerable and with underwhelming clinical efficacy; thus targeting ancillary proteins that regulate MMP activity may be a useful therapeutic approach. Extracellular matrix metalloproteinase inducer (EMMPRIN) was originally characterized as a factor present on lung cancer cells, which stimulated collagenase (MMP-1) production in fibroblasts. Subsequent studies demonstrated that EMMPRIN was identical with several other protein factors, including basigin (Bsg), all of which are now commonly termed CD147. CD147 modulates the synthesis and activity of soluble and membrane-bound [membrane-type MMPs (MT-MMPs)] in various contexts via homophilic/heterophilic cell interactions, vesicular shedding or cell-autonomous processes. CD147 also participates in inflammation, nutrient and drug transporter activity, microbial pathology and developmental processes. Despite the hundreds of manuscripts demonstrating CD147-mediated MMP regulation, the molecular underpinnings governing this process have not been fully elucidated. The present review summarizes our present knowledge of the complex regulatory systems influencing CD147 biology and provides a framework to understand how CD147 may influence MMP activity.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
CpG islands and the regulation of transcription
Deaton, A. M., & Bird, A. (2011) · Genes & Development · doi:10.1101/gad.2037511 · Cited by 3,187
Hyaluronan: from extracellular glue to pericellular cue
Toole, B. P. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1391 · Cited by 2,125
Self-citationGalectins as modulators of tumour progression
Liu, F.-T., & Rabinovich, G. A. (2005) · Nature Reviews Cancer · doi:10.1038/nrc1527 · Cited by 1,439 · cited 1×
“Galectins are a large family of lectins that bind betagalactoside moieties and perform diverse functions in biology [149, 150].”
BackgroundAnnexins: linking Ca2+ signalling to membrane dynamics
Gerke, V., Creutz, C. E., & Moss, S. E. (2005) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1661 · Cited by 1,410 · cited 1×
“Additionally, CD147 can associate with Annexin II (AnxA2), a multifunctional protein that regulates cytoskeleton organization, lipid raft dynamics, and endo/exo-cytic trafficking events [86].”
BackgroundTargeting lactate metabolism for cancer therapeutics
Doherty, J. R., & Cleveland, J. L. (2013) · Journal of Clinical Investigation · doi:10.1172/jci69741 · Cited by 1,166 · cited 1×
“MCTs tightly associate with CD147 and influence post-translational processing in the golgi as well as localization to the plasma membrane [44, 133].”
BackgroundBiswas, C., Zhang, Y., DeCastro, R., Guo, H., Nakamura, T., Kataoka, H., & Nabeshima, K. (1995) · PubMed · Cited by 716
The monocarboxylate transporter family—Structure and functional characterization
Halestrap, A. P. (2012) · IUBMB Life · doi:10.1002/iub.573 · Cited by 710 · cited 2×
“The best characterized binding partners of CD147 are MCTs, a family of transporters involved in lactate, pyruvate and ketone flux across the plasma membrane [60].”
BackgroundRevisiting the principles of microRNA target recognition and mode of action
Brodersen, P., & Voinnet, O. (2009) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2619 · Cited by 658 · cited 1×
“It is thought that ~2-6 contiguous base pairs in the seed region of miRNAs are needed for effective miRNA-mRNA duplex formation and target suppression [114]; hence the SNP in the miR-492 binding site may alter affinity to the CD147 3’-UTR resulting in differential suppression of CD147.”
BackgroundUltra-sensitive liquid biopsy of circulating extracellular vesicles using ExoScreen
Yoshioka, Y., Kosaka, N., Konishi, Y., Ohta, H., Okamoto, H., Sonoda, H., Nonaka, R., Yamamoto, H., Ishii, H., Mori, M., et al. (2014) · Nature Communications · doi:10.1038/ncomms4591 · Cited by 598 · cited 1×
“CD147-associated exosomes have been identified in malignant ascites from ovarian cancer patients [96] and in bladder cancer [97], and recent evidence suggests that CD147-containing extracellular vesicles can be extracted from cancer patient sera as a biomarker to monitor response to therapy [98].”
BackgroundPATERSON, D., JEFFERIES, W., GREEN, J., BRANDON, M., CORTHESY, P., PUKLAVEC, M., & WILLIAMS, A. (1987) · Molecular Immunology · doi:10.1016/0161-5890(87)90122-2 · Cited by 447
Cited by
Meinhardt, J., Radke, J., Dittmayer, C., Franz, J., Thomas, C., Mothes, R., Laue, M., Schneider, J., Brünink, S., Greuel, S., et al. (2021) · Nature Neuroscience · doi:10.1038/s41593-020-00758-5 · Cited by 1,458
IL-6: Relevance for immunopathology of SARS-CoV-2
Gubernatorova, E. O., Gorshkova, E. A., Polinova, A. I., & Drutskaya, M. S. (2020) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2020.05.009 · Cited by 343
Targeted therapy for head and neck cancer: signaling pathways and clinical studies
Li, Q., Tie, Y., Alu, A., Ma, X., & Shi, H. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-01297-0 · Cited by 253
Stroma in normal and cancer wound healing
Huet, E., Jaroz, C., Nguyen, H. Q., Belkacemi, Y., de la Taille, A., Stavrinides, V., & Whitaker, H. (2019) · The FEBS Journal · doi:10.1111/febs.14842 · Cited by 42
Metadata
- Authors
- Grass, G. D., & Toole, B. P.
- Venue
- Bioscience Reports
- Publisher
- Portland Press Ltd.
- Published
- 2016-01-15
- Volume
- 36
- Issue
- 1
- Pages
- e00283-e00283
- ISSN
- 0144-8463 (ISSN-L)
- 1573-4935
- OpenAlex
- W2280193287
- Cited by
- 160
- References
- 153
- FWCI
- 2.94
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.